New research suggests that individuals who discontinue blockbuster slimming jabs like semaglutide or tirzepatide can put back on lost weight far faster than those who end traditional diet and exercise plans.
Findings released in a leading health publication shows that while overweight individuals often shed a large proportion of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month once they quit.
"Users purchasing such medications should be aware of the danger of rapid weight regain when the medication concludes," stated researcher Dr. Susan Jebb.
That rate of recovery suggests a reversion to starting weight within about a year and a half.
Comparing Approaches
The analysis, which reviewed dozens of trials involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with other pills.
Researchers emphasize that individuals who lose weight through diet and exercise usually experience a less rapid creep back—around 0.1 kg a month—once they finish.
Understanding the Quick Regain
Nutrition scientists believe the mechanism of the jabs accounts for the amplified rebound.
The injections imitate a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing the hormone levels far above than normal could lead to the system to produce less of its endogenous GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication means appetite is no longer kept in check, making binge eating much more probable."
A Chronic Disease?
Health authorities suggest the jabs for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.
A number of clinicians argue that, given the likelihood of relapse, the therapy should be considered life-long.
This perspective is echoed by pharmaceutical companies, who say that the results "highlight the chronic nature of excess weight," comparing it to managing conditions like diabetes.
User Experiences
Users who have come off the jabs describe a sudden resurgence of appetite.
"It felt as if a trigger flipping and you're instantly ravenous," described one woman.
The struggle is exacerbated if users have not developed sustainable lifestyle or habit changes during therapy.
Growing Use
Figures suggest that a significant number of adults in the UK have tried these injections in the last 12 months, with interest continuing to grow.
- Adoption is greater among females compared to males.
- The 40s and 50s age group shows the greatest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
In conclusion, experts stress that while these medications are potent agents for weight loss, they are not a permanent fix and long-term success likely depends on integrated behavioural changes.
